Actively Recruiting
Comparing High-Dose and Low-Dose Intravenous and Oral Iron Treatments in Adults on Peritoneal Dialysis The PALaDIN Feasibility Study
Led by Hull University Teaching Hospitals NHS Trust · Updated on 2026-05-06
30
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Chronic kidney disease is a common condition affecting many adults, with some progressing to end-stage kidney disease requiring dialysis. This trial focuses on people undergoing peritoneal dialysis, a treatment that filters toxins by exchanging fluid in the abdomen. The study aims to evaluate the impact of different iron treatments on anaemia, a frequent complication in kidney disease due to reduced red blood cell production, by assessing which measurement best reflects meaningful changes for patients and caregivers. The study is a randomized, open-label, phase 3 feasibility trial. Participants will be randomly assigned to one of three groups oral iron tablets Ferrous Sulfate 200mg daily, low-dose intravenous iron Monofer administered reactively up to every 3 months if ferritin <100 ugL and TSAT <20%, or high-dose intravenous iron Monofer administered proactively up to every 3 months if ferritin <700 ugL and TSAT <40%. The intravenous iron dose depends on blood iron markers and body weight. The study will last for 12 months, during which the effects of these treatments on anaemia and other health measures will be monitored. During the trial, researchers will track participants anaemia response, kidney symptoms, quality of life, physical ability through a six-minute walk test, and cognitive function. They will also monitor blood transfusion frequency, need for rescue intravenous iron in the oral group, and changes in erythropoietin-stimulating agent dosages. Safety outcomes like infections and hospital admissions will be recorded. The trial includes regular assessments, symptom questionnaires, and treatment adherence checks, with follow-up lasting the full 12 months from enrollment.
CONDITIONS
Brief Title
Comparing High and Low Dose Iron Treatments for People on Peritoneal Dialysis: The PALaDIN Study
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here